• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海洋天然产物:新药浪潮?

Marine natural products: a new wave of drugs?

机构信息

Department of Medicinal Chemistry, University of Florida, Gainesville, FL 32610, USA.

出版信息

Future Med Chem. 2011 Sep;3(12):1475-89. doi: 10.4155/fmc.11.118.

DOI:10.4155/fmc.11.118
PMID:21882941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3210699/
Abstract

The largely unexplored marine world that presumably harbors the most biodiversity may be the vastest resource to discover novel 'validated' structures with novel modes of action that cover biologically relevant chemical space. Several challenges, including the supply problem and target identification, need to be met for successful drug development of these often complex molecules; however, approaches are available to overcome the hurdles. Advances in technologies such as sampling strategies, nanoscale NMR for structure determination, total chemical synthesis, fermentation and biotechnology are all crucial to the success of marine natural products as drug leads. We illustrate the high degree of innovation in the field of marine natural products, which in our view will lead to a new wave of drugs that flow into the market and pharmacies in the future.

摘要

可能蕴藏着最多生物多样性的广阔海洋世界在很大程度上尚未被探索,这可能是发现具有新颖作用模式的新型“经过验证”结构的最广阔资源,这些结构涵盖了具有生物学相关性的化学空间。这些通常复杂的分子要成功开发成药物,需要克服包括供应问题和靶点识别在内的多项挑战;然而,有办法可以克服这些障碍。采样策略、用于结构确定的纳米级 NMR、全化学合成、发酵和生物技术等技术的进步对于海洋天然产物作为药物先导物的成功至关重要。我们展示了海洋天然产物领域的高度创新性,我们认为这将导致未来有一波新药涌入市场和药店。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cd9/3210699/bee09169abd4/nihms327344f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cd9/3210699/fb6157e1fc51/nihms327344f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cd9/3210699/b87750a0e69a/nihms327344f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cd9/3210699/4bf5c19a0855/nihms327344f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cd9/3210699/1c20c2eb1891/nihms327344f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cd9/3210699/8c23c0f76643/nihms327344f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cd9/3210699/bee09169abd4/nihms327344f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cd9/3210699/fb6157e1fc51/nihms327344f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cd9/3210699/b87750a0e69a/nihms327344f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cd9/3210699/4bf5c19a0855/nihms327344f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cd9/3210699/1c20c2eb1891/nihms327344f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cd9/3210699/8c23c0f76643/nihms327344f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cd9/3210699/bee09169abd4/nihms327344f6.jpg

相似文献

1
Marine natural products: a new wave of drugs?海洋天然产物:新药浪潮?
Future Med Chem. 2011 Sep;3(12):1475-89. doi: 10.4155/fmc.11.118.
2
Recent advances and applications of experimental technologies in marine natural product research.海洋天然产物研究中实验技术的最新进展与应用
Mar Drugs. 2015 Apr 29;13(5):2694-713. doi: 10.3390/md13052694.
3
Bioactive Coumarins from Marine Sources: Origin, Structural Features and Pharmacological Properties.海洋来源的生物活性香豆素:来源、结构特征及药理特性
Curr Top Med Chem. 2015;15(17):1755-66. doi: 10.2174/1568026615666150427125916.
4
Marine Natural Products from New Caledonia--A Review.来自新喀里多尼亚的海洋天然产物——综述
Mar Drugs. 2016 Mar 16;14(3):58. doi: 10.3390/md14030058.
5
Marine Based Natural Products: Exploring the Recent Developments in the Identification of Antimicrobial Agents.海洋天然产物:探索抗菌剂鉴定的最新进展
Chem Biodivers. 2022 Oct;19(10):e202200513. doi: 10.1002/cbdv.202200513. Epub 2022 Sep 16.
6
Bluegenics: Bioactive Natural Products of Medicinal Relevance and Approaches to Their Diversification.蓝基因学:具有医学相关性的生物活性天然产物及其多样化方法。
Prog Mol Subcell Biol. 2017;55:159-186. doi: 10.1007/978-3-319-51284-6_5.
7
Marine Bacteria: A Source of Novel Bioactive Natural Products.海洋细菌:新型生物活性天然产物的来源。
Curr Med Chem. 2024;31(41):6842-6854. doi: 10.2174/0929867331666230821102521.
8
Lessons from the past and charting the future of marine natural products drug discovery and chemical biology.海洋天然产物药物发现与化学生物学的过往经验与未来展望
Chem Biol. 2012 Jan 27;19(1):85-98. doi: 10.1016/j.chembiol.2011.12.014.
9
Discovery and Development of Novel Drugs.新型药物的发现与开发
Prog Mol Subcell Biol. 2017;55:91-104. doi: 10.1007/978-3-319-51284-6_3.
10
Synthesis of Marine Natural Products and Molecules Inspired by Marine Substances.海洋天然产物与海洋物质启发的分子合成。
Mar Drugs. 2021 Apr 8;19(4):208. doi: 10.3390/md19040208.

引用本文的文献

1
Multifaceted Marine Peptides and Their Therapeutic Potential.多面海洋肽及其治疗潜力
Mar Drugs. 2025 Jul 15;23(7):288. doi: 10.3390/md23070288.
2
Penicilazaphilone C triggers ferroptosis in triple-negative breast cancer cells via the MDM2/p53/SLC7 A11/GPX4 pathway.青霉氮杂菲酮C通过MDM2/p53/SLC7A11/GPX4途径在三阴性乳腺癌细胞中引发铁死亡。
Discov Oncol. 2025 Jun 2;16(1):983. doi: 10.1007/s12672-025-02687-w.
3
The marine xanthophyll diatoxanthin as ferroptosis inducer in MDAMB231 breast cancer cells.海洋叶黄素二异岩藻黄素作为MDAMB231乳腺癌细胞中铁死亡的诱导剂。

本文引用的文献

1
Statistical Investigation into the Structural Complementarity of Natural Products and Synthetic Compounds.天然产物与合成化合物结构互补性的统计研究。
Angew Chem Int Ed Engl. 1999 Mar 1;38(5):643-647. doi: 10.1002/(SICI)1521-3773(19990301)38:5<643::AID-ANIE643>3.0.CO;2-G.
2
Eribulin mesylate.甲磺酸艾瑞布林
Nat Rev Drug Discov. 2011 Mar;10(3):173-4. doi: 10.1038/nrd3389.
3
A sea of biosynthesis: marine natural products meet the molecular age.一片生物合成的海洋:海洋天然产物迎接分子时代。
Sci Rep. 2025 Mar 9;15(1):8146. doi: 10.1038/s41598-025-91519-6.
4
Bioprospecting Bioactive Peptides in Body Mucus: From In Silico Insights to Essential In Vitro Validation.在人体黏液中生物勘探生物活性肽:从计算机模拟洞察到必要的体外验证
Mar Drugs. 2025 Feb 13;23(2):82. doi: 10.3390/md23020082.
5
Advanced Technologies for Large Scale Supply of Marine Drugs.大规模供应海洋药物的先进技术。
Mar Drugs. 2025 Feb 7;23(2):69. doi: 10.3390/md23020069.
6
Therapeutic anti-inflammatory immune potentials of some seaweeds extracts on chemically induced liver injury in mice.某些海藻提取物对化学诱导的小鼠肝损伤的治疗性抗炎免疫潜力。
Sci Rep. 2025 Feb 5;15(1):4370. doi: 10.1038/s41598-025-87379-9.
7
Two Gracilioethers Containing a [2(5H)-Furanylidene]ethanoate Moiety and 9,10-Dihydroplakortone G: New Polyketides from the Caribbean Marine Sponge .两种含有[2(5H)-呋喃亚甲基]乙酸酯部分的格拉西醚和9,10-二氢普拉科尔酮G:来自加勒比海海洋海绵的新型聚酮化合物
Appl Sci (Basel). 2024 Jan;14(1). doi: 10.3390/app14010281. Epub 2023 Dec 28.
8
Potential of Marine Sponge Metabolites against Prions: Bromotyrosine Derivatives, a Family of Interest.海洋海绵代谢产物对抗朊病毒的潜力:溴酪氨酸衍生物,一类具有研究意义的化合物。
Mar Drugs. 2024 Oct 4;22(10):456. doi: 10.3390/md22100456.
9
Stichoposide C and Rhizochalin as Potential Aquaglyceroporin Modulators.毛蕊花糖苷 C 和 Rhizochalin 作为潜在的水通道蛋白调节剂。
Mar Drugs. 2024 Jul 25;22(8):335. doi: 10.3390/md22080335.
10
Transition-Metal-Catalyzed Transformations for the Synthesis of Marine Drugs.过渡金属催化的海洋药物合成转化。
Mar Drugs. 2024 May 29;22(6):253. doi: 10.3390/md22060253.
Nat Prod Rep. 2011 Feb;28(2):411-28. doi: 10.1039/c0np90032j. Epub 2010 Dec 17.
4
Marine natural products.海洋天然产物。
Nat Prod Rep. 2011 Feb;28(2):196-268. doi: 10.1039/c005001f. Epub 2010 Dec 13.
5
A bacterium that can grow by using arsenic instead of phosphorus.一种可以利用砷而不是磷来生长的细菌。
Science. 2011 Jun 3;332(6034):1163-6. doi: 10.1126/science.1197258. Epub 2010 Dec 2.
6
Complex synthesis yields breast-cancer therapy.复杂合成产生乳腺癌治疗方法。
Nature. 2010 Dec 2;468(7324):608-9. doi: 10.1038/468608a.
7
Antiviral lead compounds from marine sponges.海洋海绵中的抗病毒先导化合物。
Mar Drugs. 2010 Oct 11;8(10):2619-38. doi: 10.3390/md8102619.
8
Identification of direct protein targets of small molecules.小分子直接蛋白质靶标的鉴定。
ACS Chem Biol. 2011 Jan 21;6(1):34-46. doi: 10.1021/cb100294v. Epub 2010 Nov 30.
9
Bryostatins: biological context and biotechnological prospects.岩大戟内酯:生物学背景与生物技术前景。
Curr Opin Biotechnol. 2010 Dec;21(6):834-42. doi: 10.1016/j.copbio.2010.09.018.
10
Frontiers and opportunities in chemoenzymatic synthesis.化学生物学酶促合成的前沿和机遇。
J Org Chem. 2010 Nov 5;75(21):7041-51. doi: 10.1021/jo101124n.